Transforming the Assessment, Prevention, and Management of Chronic Metabolic and Cardiovascular Disorders
Over the last 10 years, researchers have discovered that controlling heart disease is not merely a matter of driving serum cholesterol down; 50% of people who have a heart attack have normal cholesterol levels1. Why is this problematic? It means that for at least one out of every two patients having a heart attack, a clinician may not have addressed the risk factors that caused their heart attack. Research is shedding light on safer and more effective strategies of identifying important risk factors for preventing or reversing cardiometabolic disease, including advanced lipid assays and markers of oxidative stress, inflammation, hormone levels, and comprehensive body composition analysis.
In the following video, IFM educator Shilpa P. Saxena, MD, explains that insulin is a driving force that creates a cardiometabolic state that includes inflammation and adiposity:
Click the image to zoom
Explore Articles About Cardiometabolic Conditions
Functional Medicine Advanced Practice Modules® (APM) Cardiometabolic
Cardio 2024: January 19 - 21, 2024 | 
Livestream in Pacific Time (PT) | Up to 19.25 CME Credits Available
This module will help clinicians understand the physiology underlying cardiometabolic syndrome and cardiovascular disease, new approaches to effective assessments and treatments, and how to integrate these lifesaving tools into practice.
Shilpa P. Saxena, MD
Yousef Elyaman, MD
